BradRovin United StatesThe Ohio State University

Dr. Brad H. Rovin is the Director of the Division of Nephrology and Vice Chairman of Medicine for Research at the Ohio State University Wexner Medical Center. He is the Lee A. Hebert Distinguished Professor of Nephrology. Dr. Rovin received his Bachelor of Science in Chemical Engineering from Northwestern University in Evanston Illinois and his Doctor of Medicine from the University of Illinois Medical School in Chicago, Illinois. He completed a residency in Internal Medicine at Barnes Hospital in St. Louis Missouri, and a Fellowship in Nephrology at Washington University School of Medicine, St. Louis. Dr. Rovin studies the pathogenesis of glomerular diseases. He has a special interest in lupus nephritis. His research has focused on biomarker development for glomerular diseases. He also studies experimental therapeutics in an effort to find new treatments for glomerular diseases. Dr. Rovin established a multidisciplinary Lupus, Vasculitis and Glomerulonephritis clinic and directs an advanced fellowship in autoimmune diseases for nephrologists and rheumatologists.

Upload Picture

https://storage.unitedwebnetwork.com/files/1099/63701af96cbd813ce59a31aaa8e1655f.jpg

First name

Brad

Last name

Rovin

Institution

Country

United States

Friday, February 7, 2025

Time	Session

2:15 p.m. 3:45 p.m.	HIT! High Impact Clinical Trials – What and Why HIT1 Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland VivekKumar Chair enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE) HIT1-1 RajivAgarwal Oral Abstract Presenter ragarwal@iu.eduUnited States Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis HIT1-2 BradRovin Oral Abstract Presenter rovin.1@osu.eduUnited StatesThe Ohio State University Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial HIT1-3 KatherineTuttle Oral Abstract Presenter Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology Brahmkamal Hall - Plenary Hall

Time

Session

2:15 p.m.

3:45 p.m.

HIT! High Impact Clinical Trials – What and Why

Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland

VivekKumar Chair enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India

Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)

HIT1-1

RajivAgarwal Oral Abstract Presenter ragarwal@iu.eduUnited States
Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

HIT1-2

BradRovin Oral Abstract Presenter rovin.1@osu.eduUnited StatesThe Ohio State University
Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial

HIT1-3

KatherineTuttle Oral Abstract Presenter Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology

Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Debunking Nephrology Myths: Insights From Global Kidney Care Leaders BKH2003 SanjayPandya Chair saveyourkidney@gmail.comIndiaConsulting Nephrologist, Wockhardt Hospital & Jalaram Hospital, Rajkot SreejithParameswaran Chair sparameswaran@outlook.comIndiaProfessor & Head, Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Revisiting Kidney Biopsies: Why More Than One Can Be Beneficial BKH2003-01 BradRovin Speaker rovin.1@osu.eduUnited StatesThe Ohio State University Genetic Testing for Kidney Disease Is Not Complicated BKH2003-02 KelsieBogyo Speaker kb3164@cumc.columbia.eduUnited StatesColumbia University Irving Medical Center Thrombotic Microangiopathy Workup: Everything You Need to Know BKH2003-03 AnujaJava Speaker ajava@wustl.eduUnited StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS Dealing With Biological Variability in Albuminuria and Creatinine BKH2003-04 SusrutWaikar Speaker swaikar@partners.orgUnited StatesBoston University Chobanian and Avedisian School of Medicine, and Boston Medical Center The Underdiagnosis of Primary Aldosteronism in Clinical Practice BKH2003-05 VivekBhalla Speaker vbhalla@stanford.eduUnited StatesDirector, Stanford Hypertension Center; Division of Nephrology, Stanford University School of Medicine Q&A BKH2003-06 Brahmkamal Hall - Plenary Hall	The ISN-KI/KIR Editorial Fellows Session: The Best of 2024/25 Articles KI/KIR1 BradRovin Chair rovin.1@osu.eduUnited StatesThe Ohio State University GermaineWong Chair germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney PierreRonco Chair pierreronco@yahoo.frFranceHôpital Tenon Kidney International in Focus: Annual Highlights KI/KIR1-01 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon ISN-KI Fellows: Showcasing Excellence Part 1 KI/KIR1-02 Eugene Yu HinChan Speaker genegene.chan@gmail.comHong Kong, ChinaThe Chinese University of Hong Kong, Hong Kong Children's Hospital ISN-KI Fellows: Showcasing Excellence Part 2 KI/KIR1-03 IsabelleAyoub Speaker isabelle.ayoub@osumc.eduUnited StatesThe Ohio State University ISN-KI Fellows: Showcasing Excellence Part 3 KI/KIR1-04 ChristophKuppe Speaker ckuppe@ukaachen.deGermanyDepartment of Nephrology, RWTH University Aachen, Germany ISN-KI Fellows: Showcasing Excellence Part 4 KI/KIR1-05 GriffithPerkins Speaker griffith.perkins@adelaide.edu.auAustralia Q and A Kidney International Reports in Focus: Annual Highlights KI/KIR1-06 JaiRadhakrishnan Speaker jr55@cumc.columbia.eduUnited StatesColumbia University in the City of New York Kidney International Reports in Focus: Annual Highlights KI/KIR1-07 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Kidney International Reports in Focus: Annual Highlights KI/KIR1-08 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland Q and A Celebrating Excellence: Best Reviewer Awards Presentation KI/KIR1-09 BradRovin Speaker rovin.1@osu.eduUnited StatesThe Ohio State University Recognizing the Best: Basic Science Awards for Early Career Researchers KI/KIR1-10 VeronicaMiguel Speaker vmiguh00@gmail.comSpainSpanish National Centre for Cardiovascular Research Recognizing the Best: Clinical Science Awards for Early Career Researchers KI/KIR1-11 MuzamilHassan Speaker muzlamide@yahoo.comNigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Recognizing the Best: ISN-KI Editorial Fellows Awards KI/KIR1-12 GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney Champa Hall 304
2:15 p.m. 3:45 p.m.	Speed Dating with KI/KIR Editors KI/KIR2 BradRovin Chair rovin.1@osu.eduUnited StatesThe Ohio State University GermaineWong Chair germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney PierreRonco Chair pierreronco@yahoo.frFranceHôpital Tenon Introduction KI/KIR2 -1 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon Translational Science/Genomics KI/KIR2-2 ChristophKuppe Speaker ckuppe@ukaachen.deGermanyDepartment of Nephrology, RWTH University Aachen, Germany KrzysztofKiryluk Speaker kk473@columbia.eduUnited StatesColumbia University Discovery Science KI/KIR2-3 ReikoInagi Speaker inagi-r@m.u-tokyo.ac.jpJapanThe University of Tokyo Graduate School of Medicine VeronicaMiguel Speaker vmiguh00@gmail.comSpainSpanish National Centre for Cardiovascular Research Crossing the Lines to ‘Acceptance’ in High Impact Kidney Journals KI/KIR2-5 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Epidemiology/Stats/Policy Forum KI/KIR2-6 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney MuzamilHassan Speaker muzlamide@yahoo.comNigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Clinical Trials KI/KIR2-4 BradRovin Speaker rovin.1@osu.eduUnited StatesThe Ohio State University Kesar Hall 202